Increased fetal blood pressure response to maternal norepinephrine after pharmacological inhibition f norepinephrine uptake in pregnant sheep

Acta Paediatrica, International Journal of Paediatrics

Volumn 96, Issue 5, 2007, Pages 650-654

  Hansson, S R ^a   Bottalico, B ^a   Amer Wahlin, I ^a   Marsal K ^a   Ley, D ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Blood flow; Hypertension; Monoamine transporter; Placenta; Reboxetine

Indexed keywords

NORADRENALIN; NORADRENALIN TRANSPORTER; REBOXETINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; FETUS; FETUS BLOOD PRESSURE; MATERNAL BLOOD; NONHUMAN; PLACENTA; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; SHEEP;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; BLOOD PRESSURE; FEMALE; FETUS; MORPHOLINES; NOREPINEPHRINE; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; PREGNANCY; SHEEP;

EID: 34247520554     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2007.00262.x     Document Type: Article

References (47)

1. Khong TY, De Wolf F, Robertson WB, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and small-for-gestational age infants. British Journal of Obstetrics and Gynecology 1986 93 : 1049 59.
2. Kaufmann P, Black S, Huppertz B. Endovascular trophoblast invasion: Implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod 2003 69 : 1 7.
3. Schobel HP, Fischer T, Heuszer K, Geiger H, Schmieder RE. Preeclampsia-a state of sympathetic overactivity. N Engl J Med 1996 335 : 1480 5.
4. Manyonda IT, Fenske C, Hole D, Choy MY, Wilson C. A role for noradrenaline in pre-eclampsia: Towards a unifying hypothesis for the pathophysiology. British Journal of Obstetrics and Gynaecology 1998 105 : 641 8.
5. Amara SG, Kuhar MJ. Neurotransmitter transporters: Recent progress. AnnuRevNeurosci 1993 16 : 73 93.
6. Brownstein MJ, Hoffman BJ. Neurotransmitter transporters. Recent Prog Horm Res 1994 49 : 27 42.
7. Hoffman BJ, Hansson SR, Mezey E, Palkovits M. Distribution of monoamine neurotransmitter transporters in the rat brain. Frontiers in Neuroendocrinology 1998.
8. Hoffman BJ, Mezey E, Brownstein MJ. Cloning of a serotonin transporter affected by antidepressants. Science 1991 254 : 579 80.
9. Pacholczyk T, Blakely RD, Amara SG. Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature 1991 350 : 350 4.
10. Kilty JE, Lorang D, Amara SG. Cloning and expression of a cocaine-sensitive rat dopamine transporter. Science 1991 254 : 578 9.
11. Borowsky B, Hoffman BJ. Neurotransmitter transporters: Molecular biology, function, and regulation. Internal Rev Neurobiology 1995 38 : 139 99.
12. Chang AS, Chang SM, Starnes DM, Schroeter S, Bauman AL, Blakely RD. Cloning and expression of the mouse serotonin transporter. Brain Res Mol Brain Res 1996 43 : 185 92.
13. Hansson SR, Mezey E, Hoffman BJ. Serotonin transporter mrna expression in neuronal crest-derived structures and sensory pathways of the developing rat embryo. Neuroscience 1998 89 : 243 65.
14. Zhang L, Dresser MJ, Gray AT, Yost SC, Terashita S, Giacomini KM. Cloning and functional expression of a human liver organic cation transporter. Molecular Pharmacology 1997 51 : 913 21.
15. Gorboulev V, Ulzheimer JC, Akhoundova A, Ulzheimer-Teuber I, Karbach U, Quester S, et al. Cloning and characterization of two human polyspecific organic cation transporters. DNA Cell Biol 1997 16 : 871 81.
16. Koehler MR, Wissinger B, Gorboulev V, Koepsell H, Schmid M. The human organic cation transporter genes slc22a1 and slc22a2 are located on chromosome 6q26. Cytogenet Cell Genet 1997 79 : 198 200.
17. Grundemann D, Schechinger B, Rappold GA, Schomig E. Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter. Nat Neurosci 1998 1 : 349 51.
18. Kekuda R, Prasad PD, Wu X, Wang H, Fei Y-J, Leibach FH, et al. Cloning and functional characterization of a potential-sensitive, polyspecific organic cation transporter (oct3) most abundantly expressed in placenta. Journal of Biological Chemistry 1998 273 : 15971 9.
19. Hayer-Zillgen M, Bruss M, Bonisch H. Expression and pharmacological profile of the human organic cation transporters hoct1, hoct2 and hoct3. Br J Pharmacol 2002 136 : 829 36.
20. Bzoskie L, Blount L, Kashiwai K, Tseng YT, Hay WWJ, Padbury J. Placental norepinephrine clearance: In vivo measurement and physiological role. Am J Physiol 1995 269 1 Pt 1 : E145 149.
21. Prasad PD, Hoffmans BJ, Moe AJ, Smith CH, Leibach FH, Ganapathy V. Functional expression of the plasma membrane serotonin transporter but not the vesicular monoamine transporter in human placental trophoblasts and choriocarcinoma cells. Placenta 1996 17 : 201 7.
22. Balkovetz DF, Tiruppathi C, Leibach FH, Mahesh VB, Ganapathy V. Evidence for an imipramine-sensitive serotonin transporter in human placental brush-border membranes. J Biol Chem 1989 264 : 2195 8.
23. Bottalico B, Larsson I, Casslen B, Broszki J, Hernandez-Andrade E, Marsal K, et al. Norepinephrine (NET), serotonin (SERT), vesicular monoamine (VMAT2) and organic cation transporters (OCT1,2 and EMT) in human placenta from preeclamptic and normotensive pregnancies". Placenta 2004 25 : 518 29.
24. Ramamoorthy S, Ramamoorthy JD, Prasad PD, Bhat GK, Mahesh VB, Leibach FH, et al. Regulation of the human serotonin transporter by interleukin-1 beta. Biochem Biophys Res Commun 1995 216 : 560 7.
25. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: An endothelial cell disorder. Am J Obstet Gynecol 1989 161 : 1200 4.
26. Prasad PD, Leibach FH, Mahesh VB, Ganapathy V. Human placenta as a target organ for cocaine action: Interaction of cocaine with the placental serotonin transporter. Placenta 1994 15 : 267 78.
27. Towers CV, Pircon RA, Nageotte MP, Porto M, Garite TJ. Cocaine intoxication presenting as preeclampsia and eclampsia. Obstet Gynecol 1993 81 : 545 7.
28. Padbury JF, Tseng YT, McGonnigal B, Penado K, Stephan M, Rudnick G. Placental biogenic amine transporters: Cloning and expression. Brain Res Mol Brain Res 1997 45 : 163 8.
29. Eisenhofer G. The role of neuronal and extraneuronal plasma membrane transporters in the activation of peripheral catecholamines. Pharmacology and therapeutics 2001 91 : 35 62.
30. Eisenhofer G, Kopin IJ, Goldstein DS. Catecholamine metabolism: A contemporary view with implications for physiology and medicine. Pharmacol Rev 2004 56 : 331 49.
31. Kadhe NG, Chillar AJ, Deshmukh YA. Reboxetine: A novel antidepressant. J Postgrad Med 2003 49 : 373 5.
32. Preskorn SH. Reboxetine: A norepinephrine selective reuptake pump inhibitor. J Psychiatr Pract 2004 10 : 57 63.
33. Ohman D, Norlander B, Peterson C, Bengtsson F. Bioanalysis of racemic reboxetine and its desethylated metabolite in a therapeutic drug monitoring setting using solid phase extraction and HPLC. Ther Drug Monit 2001 23 : 27 34.
34. Pellizzoni C, Poggesi I, Jorgensen NP, Edwards DM, Paus E, Strolin Benedetti M. Pharmacokinetics of reboxetine in healthy volunteers. Single against repeated oral doses and lack of enzymatic alterations. Biopharm Drug Dispos 1996 17 : 623 33.
35. Dostert P, Benedetti MS, Poggesi I. Review of the pharmacokinetics and metabolism of reboxetine, a selective noradrenaline reuptake inhibitor. Eur Neuropsychopharmacol 1997 7 Suppl 1 : S23 35 discussion S71-23.
36. Smolich JJ, Esler MD. Total body catecholamine kinetics before and after birth in spontaneously hypoxemic fetal lambs. Am J Physiol 1999 277 : R1313 20.
37. Ganapathy V, Ramamoorthy S, Leibach FH. Transport and metabolism of monoamines in the human placenta. Trophoblast Research 1993 7 : 35 51.
38. Sjostrom K, Valentin L, Thelin T, Marsal K. Maternal anxiety in late pregnancy and fetal hemodynamics. Eur J Obstet Gynecol Reprod Biol 1997 74 : 149 55.
39. Sjostrom K, Valentin L, Thelin T, Marsal K. Maternal anxiety in late pregnancy: Effect on fetal movements and fetal heart rate. Early Hum Dev 2002 67 : 87 100.
40. Misenhimer HR, Margulies SI, Panigel M, Ramsey EM, Donner MW. Effects of vasoconstrictive drugs on the placental circulation of the rhesus monkey. A preliminary report. Invest Radiol 1972 7 : 496 9.
41. Laporte R, DeRoth L. Modulation of the effects of norepinephrine uptake inhibitors on the norepinephrine-induced contractile response of the porcine uterine artery during early pregnancy. Can J Vet Res 1997 61 : 214 20.
42. Galan HL, Anthony RV, Rigano S, Parker TA, de Vrijer B, Ferrazzi E, et al. Fetal hypertension and abnormal doppler velocimetry in an ovine model of intrauterine growth restriction. Am J Obstet Gynecol 2005 192 : 272 279.
43. Chaddha V, Viero S, Huppertz B, Kingdom J. Developmental biology of the placenta and the origins of placental insufficiency. Semin Fetal Neonatal Med 2004 9 : 357 69.
44. Simonetta G, Rourke AK, Owens JA, Robinson JS, McMillen IC. Impact of placental restriction on the development of the sympathoadrenal system. Pediatr Res 1997 42 : 805 11.
45. Bzoskie I, Blount I, Kashiwai K, Humme J, Padbury JF. Placental norepinephrine transporter development in the ovine fetus. Placenta 1997 18 : 65 70.
46. Thomas SA, Matsumoto AM, Palmiter RD. Noradrenaline is essential for mouse fetal development. Nature 1995 374 : 643 6.
47. Godfrey KM. The role of the placenta in fetal programming-a review. Placenta 2002 23 : S20 27.